Carregant...
Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers
Trial data support an absence of an exposure–survival relationship for pembrolizumab. As these relationships remain unexamined in a real‐world setting, we determined them in metastatic melanoma prospectively in an observational study. Translational objectives included identifying biomarkers of progr...
Guardat en:
| Publicat a: | Pharmacol Res Perspect |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204864/ https://ncbi.nlm.nih.gov/pubmed/34129290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.808 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|